Standout Papers

Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated <i>KRAS</i> G12C 2023 2026 2024140
  1. Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C (2023)
    Marwan Fakih, Lisa Salvatore et al. New England Journal of Medicine
  2. Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial (2024)
    Yasutoshi Kuboki, Marwan Fakih et al. Nature Medicine

Citation Impact

64 standout
Sub-graph 1 of 22

Citing Papers

The present and future of bispecific antibodies for cancer therapy
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
3 intermediate papers

Works of Qui Tran being referenced

Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia
2019
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia
2018
and 1 more

Author Peers

Author Oncology PRM Hematology Molecular Biology PFM Last Decade Papers Cites
Qui Tran 413 118 58 189 144 34 629
Joseph G. Rayback 19 221
Julia Burt 4 1 1 1 3 251
Boris Klebansky 31 3 33 173 12 11 610
Elma S. Frias 10 62 2 198 9 13 646
L. Chinsoo Cho 69 495 14 10 7 636

All Works

Loading papers...

Rankless by CCL
2026